Publications by authors named "Shaymaa Ashi"

Granular cell tumors (GCTs) are rare, indolent neoplasms classically characterized by eosinophilic granular cytoplasm, infiltrations of polygonal cells in the collagenous stroma, and pustulo-ovoid bodies of Milian. We describe a case of a 10-year-old female presenting with a GCT of the upper arm, remarkable for positive Melan-A expression without additional melanocytic features. The differentiation between granular cells versus melanocytic neoplasms carries significant implications for clinical management, and such diagnoses should be considered carefully in the setting of unusual immunophenotypes.

View Article and Find Full Text PDF
Article Synopsis
  • - Squamoid eccrine ductal carcinoma (SEDC) is a rare and underrecognized sweat gland cancer that poses risks for local recurrence and metastasis, with a distinct biphasic differentiation pattern resembling well-differentiated cutaneous squamous cell carcinoma (cSCC) and infiltrative ductal specificity.
  • - Diagnosis relies solely on histopathologic examination, and while its development remains poorly understood, a genetic analysis through whole-exome sequencing has identified multiple mutations that overlap with those found in cSCC but differ from other sweat gland cancers.
  • - The findings suggest that SEDC may start as a well-differentiated cSCC before evolving into a sweat gland-like tumor, highlighting the need for
View Article and Find Full Text PDF

Background/objectives: Follicular keratosis (FK) is a poorly understood disorder presenting with multiple, grouped hyperkeratotic follicular papules typically affecting the chin or jawline. This study describes the clinical presentation, histopathology, management, and outcomes of a series of pediatric patients of color with FK of the face, thought to be related to rubbing or friction on the skin.

Methods: Retrospective review of 20 pediatric patients with FK of the face who presented to our pediatric dermatology practice between April 2019 and October 2021.

View Article and Find Full Text PDF

Immune checkpoint inhibitors are increasingly being used in the treatment of various solid organ and hematologic malignancies. Dermatologic toxicities associated with programmed cell death protein-1 (PD-1) and programmed death ligand-1 (PD-L1) therapy have been widely reported in the literature. It is important for clinicians to be aware of these toxicities to ensure prompt recognition and treatment.

View Article and Find Full Text PDF